W5 Learner Assessment Survey

Thank you for watching the video of Workshop 5 filmed at ICS 2018, Philadelphia. You can now assess yourself by undertaking a short multiple choice questionnaire. This will help you identify how much you learnt from the workshop. If you wish you can enter your name and email at the end and the ICS office will send you a certificate to state that you have undertaken the test. Please note this workshop is not currently accredited for online CME.

Good luck and have fun!

Question Title

* 1. In regards to LUTS in patients with Parkinson disease, please indicate which of the following is correct:

A) May be related to the bladder

B) May be a consequence of treatment

C) May be integrated part of the syndrome

D) May be related to BOO

E) All the previous are correct

Question Title

* 2. Which one of the following is the most common urinary symptom in patients with Parkinson disease?

A) Urgency

B) Urgency incontinence

C) Frequency

D) Nocturia

E) Hesitancy

Question Title

* 3. Complete the following statement: Hypertonic PFM...

A) Can be assessed by palpating on the outside of the body

B) Does not need to be assessed in the patient with neurological disease

C) Increased muscle tone related to contractile or vasoelastic components

D) Is associated with urinary incontinence

E) Results is a wide and weak PFM

Question Title

* 4. Complete the following statement: Surface EMG...

A) Adipose tissue and hair do not affect the amount of muscle activity registered

B) Can measure the contractile portion of PFM resting tone

C) Does not measure a paradoxical contraction during bearing down

D) Is not used to assess the PFM of a patient with neurological disease

E) Measures blood flow in smooth muscles

Question Title

* 5. Ideas to promote full voiding include:

A) Allowing the feet to hang in the air

B) Hovering or squatting over the toilet

C) Leaning forward, standing , try to void again

D) Tighten the PFM while bearing down

E) Watching the patient and talking to them as they void

Question Title

* 6. The best candidate for conservative management of UI in patients with Multiple Sclerosis (MS):

A) Exhibits a low PVR

B) Has PFM spasticity and dyssynergia

C) Lives with a 24 hour caregiver

D) Severity of functional limitation of MS will not affect outcome

E) Requires assistance for transfers

Question Title

* 7. How to consider failure of treatment in neurogenic detrusor overactivity?

A) No improvement of symptoms

B) Failure in the enhancement of urodynamic evaluation

C) Repeated urinary tract infections

D) Negative impact on Quality of Life

E) All of the above

Question Title

* 8. Tailoring the treatment of neurogenic detrusor overactivity. Select the best answer.

A) Understanding of the patient’s necessities, kidney function

B) Hand dexterity, urinary tract infection

C) Preference of the patient, hand dexterity, cognitive aspect

D) Urinary tract infection, kidney function

E) Kidney function, hand dexterity, urinary tract infection

Question Title

* 9. An open bladder neck during filling phase, as seen in videourodynamics studies, is:

A) More frequently seen in Multiple Systemic Athrophy (MSA) than in Parkinson disease (PD)

B) A videourodynamic pattern patognomic of MSA

C) Is a sign of sympathetic pathway disturbance

D) Is as frequent in PD as it is in MSA

E) Is cause by bladder denervation

Question Title

* 10. Videourodynamics are useful in neurogenic patients in detecting:

A) Vesicoureteral reflux

B) Anatomic variations of the bladder, including trabeculations, saccules or diverticula, and filling defects

C) Bladder neck function and coordination during micturition

D) Dysfunctional voiding/pelvic floor dysfunction

E) All of the above

Question Title

* 11. The key point to restore quality of life in patients with neurogenic detrusor overactivity is based on the treatment of:

A) Nocturia

B) Urinary incontinence

C) Urgency

D) Hesitancy

E) Nocturnal enuresis

Question Title

* 12. The SYNERGY Study was a trial conducted to test:

A) Solifenacine (S) vs Mirabegron (M) vs Combined therapy (S and M)

B) Solifenacine (S) vs Mirabegron (M) vs Placebo

C) Solifenacine (S) vs Mirabegron (M) vs Combined therapy (S and M) vs Placebo

D) Solifenacine (S) vs Mirabegron (M) vs Combined therapy (S and M and Darifenacine)

E) None of the above

Question Title

* 13. Immediatly after a stroke, the most frequent clinical presentation of the detrusor activity is:

A) Detrusor overactivity without urinary incontinence

B) Detrusor underactivity

C) Detrusor overactivity and Sphincter dyscinergia

D) Arreflexia

E) Detrusor overactivity with urinary urge incontinence

Question Title

* 14. In patients with NDO the most common cause of bladder oulet obstruction is:

A) Prostate enlargement

B) Prostate obstruction

C) Urethral stricture due to constant manipulation

D) Sphincter dyssynergia

E) Pelvic floor dysfunction

Question Title

* 15. If you would like a certificate to be emailed to you, stating that you have completed this assessment, then please enter your name and email address here:

First Name

Surname

Email Address